Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Crop Life ScienceNSE:CLSL +0.46%55 EV-to-EBITDA is 8.47 as of Aug. 03, 2026, which is 8% above its 10-year median of 7.85. GuruFocus rates NSE:CLSL with a GF Score™ of 55/100 and a GF Value™ of ₹55.74 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 212 Agriculture companies, Crop Life Science ranks better than 56.13% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Crop Life Science's enterprise value is ₹1,702 Mil.
Crop Life Science's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹201 Mil. Therefore, Crop Life Science's EV-to-EBITDA for today is 8.47.
The historical rank and industry rank for Crop Life Science's EV-to-EBITDA or its related term are showing as below:
NSE:CLSL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.69 Med: 7.85 Max: 9.16
Current: 8.47
During the past 7 years, the highest EV-to-EBITDA of Crop Life Science was 9.16. The lowest was 6.69. And the median was 7.85.
NSE:CLSL's EV-to-EBITDA is ranked better than 56.13% of 212
companies
in the Agriculture industry
Industry Median: 9.4
vs NSE:CLSL: 8.47
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Crop Life Science (NSE:CLSL) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Crop Life Science's PE Ratio (TTM) for today is calculated as:
Crop Life Science's share price for today is ₹66.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Crop Life Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3.790.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Crop Life Science's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CLSL vs CTVA, CF, MOS: EV-to-EBITDA Comparison
For the Agricultural Inputs subindustry, Crop Life Science's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crop Life Science EV-to-EBITDA vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Crop Life Science's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Crop Life Science's EV-to-EBITDA falls into.
Crop Life Science's current Enterprise Value is ₹1,702 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Crop Life Science's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹201 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Crop Life Science (NSE:CLSL) has a EV-to-EBITDA of 8.47 as of Aug. 03, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Crop Life Science. This is near median its historical median of 7.85. Over the past decade, Crop Life Science's EV-to-EBITDA has ranged from 6.69 to 9.16. According to the industry distribution chart, Crop Life Science ranks #93 out of 212 companies in the Agriculture industry, placing it in the top 43.9%.
Is Crop Life Science's EV-to-EBITDA too high?
Crop Life Science's current EV-to-EBITDA of 8.47 is near median its 10-year median of 7.85. Over the past 10 years, this metric has ranged from a low of 6.69 to a high of 9.16. The Agriculture industry median EV-to-EBITDA is 9.40. Crop Life Science's value of 8.47 is 9.9% below this industry median. Based on the distribution chart, Crop Life Science ranks #93 out of 212 companies in the Agriculture industry, which is above the industry midpoint. Overall, Crop Life Science has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's EV-to-EBITDA compare to CTVA and CF?
According to the Agriculture industry distribution chart, Crop Life Science ranks #93 out of 212 companies for EV-to-EBITDA. This puts Crop Life Science in the upper half of its industry. The industry median EV-to-EBITDA is 9.40. Crop Life Science's value of 8.47 is 9.9% below this benchmark. Historically, Crop Life Science's own EV-to-EBITDA has ranged from 6.69 to 9.16 over the past decade. While the company's 10-year median is 7.85 vs. the industry median of 9.40, Crop Life Science has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for an Agriculture company?
The median EV-to-EBITDA among Agriculture companies is 9.40, based on 212 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Crop Life Science's current EV-to-EBITDA of 8.47 is 9.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Crop Life Science. For the Agriculture industry, the median EV-to-EBITDA is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crop Life Science's current EV-to-EBITDA is 8.47, which is near median its own 10-year median of 7.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹55.74, compared to a current price of ₹66.20 — trading 18.8% above its estimated fair value. The current EV-to-EBITDA is 8.47, which is near median its 10-year median of 7.85 and 9.9% below the Agriculture industry median of 9.40. Crop Life Science's overall GF Score™ is 55/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current EV-to-EBITDA is 8.47 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crop Life Science (NSE:CLSL) Overvalued in 2026?
Based on GuruFocus' analysis, Crop Life Science stock appears to be overvalued.
The current stock price of ₹66.20 is trading 18.8% above its estimated GF Value™ of ₹55.74.
GuruFocus considers Crop Life Science to be Modestly Overvalued.
Key valuation signals for NSE:CLSL:
EV-to-EBITDA: 8.47 (near median its 10-year median of 7.85)
GF Value™: ₹55.74 vs. price of ₹66.20 (18.8% above fair value)
Industry Position: 9.9% below the Agriculture median (#93 of 212)
No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
55GF Score
Get the complete analysis for NSE:CLSL
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CLSL has been successfully added to your 
